Artificial intelligence (AI) is rapidly shaping the landscape of gastroenterology and endoscopy, offering new opportunities to improve diagnostics, treatment, and workflow efficiency. Despite numerous AI applications being explored in academic research, regulatory authorization remains a bottleneck, limiting real-world adoption. This paper explores the role of industry in fostering AI integration by addressing ethical considerations, regulatory pathways, data security, and commercialization strategies.
Trending
- Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research (Business Wire)
- Private Equity vs. Independent Medicine: When Wall Street Enters the Exam Room (Working Healthcare – the Podcast Fixing Healthcare)
- Artificial Intelligence Is Not the End of the Physician (JAMA)
- Charted: The most (and least) burned out physician specialties (Advisory Board)
- Growth, practice value and mergers: A strategic guide for physicians (Medical Economics)
- The potential ‘litigation wave’ headed for GI (Becker’s GI & Endoscopy)
- Groundbreaking new study shows real-time AI platform better at diagnosing cancer than biopsy (UMass Chan Medical School)
- Investigational endoscopic therapy maintains weight after GLP-1 discontinuation (GI & Hepatology News)
